CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

William Nes, C M Calvet, G Jennings, W. Zhou, A Aksenov, M R Luth, R Abagyn, William David Nes, J H Mckerrow, Larissa M Podust

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e0006104
JournalPlos Neglected Tropical Disease
StatePublished - Dec 15 2017

Fingerprint Dive into the research topics of 'CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)'. Together they form a unique fingerprint.

Cite this